文献速递消化内镜消化道肿瘤与早癌

随机卫生服务研究中结肠镜筛查项目的死亡率和住院率

Mortality and Rate of Hospitalization in a Colonoscopy Screening Program From a Randomized Health Services Study.
PubMed 文献 · Clin Gastroenterol Hepatol · 2019-09-13

该研究基于波兰结肠镜筛查项目(PCSP),将55-64岁人群按1:1分配至受邀筛查组(n=338,477)或5年后受邀的匹配对照组(n=338,557),比较实际或虚拟结肠镜日期前后死亡率和非计划住院率。

要点

  • 结肠镜筛查不增加结肠镜前后死亡率。
  • 意向性分析中筛查组非计划住院率轻度升高。
  • 住院增加主要与结肠镜相关且发生在检查后。

核心结论

  • 结肠镜作为筛查干预不增加结肠镜前后死亡率,但可能与非计划住院的小幅显著增加相关,尤其在结肠镜检查完成后。

研究设计与样本

  • 基于波兰结肠镜筛查项目(PCSP)的随机卫生服务研究,2012至2015年将55-64岁居民按1:1分配至受邀筛查组(n=338,477)或5年后受邀的匹配对照组(n=338,557),筛查组中55,390人(16.4%)实际接受结肠镜检查,死亡和住院数据来自国家登记处。

临床怎么用

  • 结肠镜筛查咨询时可告知患者不增加死亡风险,但存在小幅非计划住院风险,尤其检查后。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: It is difficult to quantify adverse events related to screening colonoscopy due to lack of valid and adequately powered comparison groups. We compared mortality and rate of unplanned hospitalizations among subjects who underwent screening colonoscopies within the Polish Colonoscopy Screening Program (PCSP) vs unscreened matched controls in Poland. METHODS: Persons 55-64 years old living in the area covered by the PCSP from 2012 through 2015 were assigned in a (1:1) to a group invited for screening colonoscopy (n = 338,477) or a matched group that would be invited 5 years later (controls, n = 338,557). All subjects in the screening group were assigned proposed screening colonoscopy dates (actual dates when invitees confirmed or rescheduled colonoscopy) and those in the control group were assigned virtual dates corresponding to the matched individuals from the screening group. In the screening group, 55,390 subjects (16.4%) underwent screening colonoscopy. Mortality and hospitalization data were obtained from National Registries. We compared mortality and rate of hospitalization between the groups for defined intervals before and after colonoscopy date. Hospitalizations were divided into related and unrelated to colonoscopy based on ICD codes by 3 specialists. Our primary aim was to compare mortality and hospitalization 6 weeks before and 30 days following the actual or virtual date of colonoscopy in the screening or control group. RESULTS: In the intent to treat analysis, overall there were no significant differences in mortality between the colonoscopy group and control group (0.22% vs 0.22%; risk difference less than .01%; 95% CI, decrease of 0.02% to 0.02%; P = .913). The overall rate of unplanned hospitalization was significantly higher for the colonoscopy group (2.39% vs 2.31% for the control group; risk difference, 0.08%; 95% CI, 0.01%-0.15%; P=.026) for the entire observation period. This was due to the higher rate of hospitalizations after screening (1.10% vs 1.01% for the control group; risk difference, 0.09%; 95% CI, 0.04%-0.14%; P < .001) including higher proportion of hospitalizations that were assessed as related to colonoscopy (0.24% vs 0.22% for the control group; risk difference, 0.02%; 95% CI, 0.00%-0.05%; P = .046). In the per-protocol analysis, the overall rate of hospitalizations did not differ significantly between control and screening colonoscopy groups (1.87% vs 1.90%; P=.709). However, screening colonoscopy did increase rates of related hospitalizations after the date of screening (from 0.14% to 0.31%; P < .001). CONCLUSIONS: In an analysis of data from the PCSP, we found high-quality evidence that colonoscopy as a screening intervention does not increase mortality before or after colonoscopy. However, it may be associated with a small but significant increase in unplanned hospitalizations, especially after the colonoscopy is completed.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Kobiela J, Spychalski P, Wieszczy P, et al. Mortality and Rate of Hospitalization in a Colonoscopy Screening Program From a Randomized Health Services Study. Clin Gastroenterol Hepatol. 2019. PMID: 31525515. doi:10.1016/j.cgh.2019.09.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。